RE:RE:RE:RE:RE:RE:RE:ONCY's pelareorep can provide a fine T-cell boost for ADCs
Doing comparisons it would be nice if onc is being considered for a BO as opposed to a partnership as it ends all uncertainty surrounding the company.
As to IMmunoGEn, I believe that they were worth in the billions before being acquired from looking at ther chart so hard to compare that with onc which at this time is trading under 100 million U.S.
I think most would be happy if we got anything north of 2 billion considering all that the company has been through. Hard to say what the inflection point is or will be as there is a lot going on so tough to say when someone will pull the trigger. Originally it was supposed to be Aware1, then Bracelet, then Goblet, then OS for the MBC and now maybe the FDA type C meeting results.
Something needs to give and soon as bottom line they either need a partnerhsip to fund the phase 3 trials or they need a BO.